A20 knockdown in GSCs promotes apoptosis and reduces tumorigenic potential in mouse models of human cancer, but overexpression of A20 in A20-deficient lymphoma cells produces similar results [46],[47]. This evidence concerns the gene TNFAIP3 and cancer.